A Nightmare on BIO 2012 Exhibition Street
BOSTON ‑ After crisscrossing the exhibition hall and three Boston zip codes yesterday for my citywide BIO 2012 reception scavenger hunt and finding a belly full of German sausages, Chinese dim sum, French pastries, Japanese sake and Irish whiskey to…
#BIO2012: Tips for a Wicked Good Meeting
Heading to Boston next week for the 2012 Biotechnology Industry Organization International convention? So are we. In fact, BioWorld has attended and exhibited at the annual BIO meeting for 18 years, so we know a thing or two about navigating…
Fathers, Stop Being Such . . . Men!
June is not only for Father’s Day greetings; it is also Men’s Health Month. And if any gender needs an aide memoire to engender the self-awareness to regard and conduct its health, it would be men!
Mamma Mia! It’s Biopharma Season!
“Hey kids, let’s put on a show!” That was a famous line from the 1937 Broadway musical, Babes in Arms, shouted to exhort the old gang to take action to save the orphanage. As the theater market just put on…
To BioWorld: Farewell! All My Best. With Love, Trista
As many of you know, after six wonderful years with BioWorld, I’m moving on to take a position as associate director of corporate communications with Ironwood Pharmaceuticals.
@ASCO12: Invisible Gorillas, IgNobel Prizes and What it All Means for Drug Discovery
As I may have mentioned before, I love the IgNobel Prizes. So imagine my delight when I found myself in a session at ASCO’s 2012 annual meeting earlier this week listening to the speaker, Anthony Tolcher, talking about The Invisible…
It’s the Pounds, Stupid
At a family wedding earlier this month, an uncle was salivating over the prospect that the Vivus Inc. drug Qnexa could soon become the first in a new generation of obesity drugs to gain FDA approval. He needed to lose…
What Drug Problem?
Pop quiz . . . which market is valued higher, illegal drugs or prescription drugs?
The EMA’s Shambolic Handling of Glybera
If you can’t see the wood for the trees the common sense response is to do a little thinning and let the light shine through.
Big Pharma’s Vanishing Act
It wasn’t exactly love at first sight back in 1976 when Genentech Inc. became of legal age to go forth and incorporate, but the platonic relationship between biotech and pharma has increasingly mellowed over the ensuing 36 years into an…
Join the Conversation